{"id":174579,"date":"2026-01-05T07:30:00","date_gmt":"2026-01-05T12:30:00","guid":{"rendered":"https:\/\/testing.news-you-need.com\/index.php\/2026\/01\/05\/sanofis-2nd-autoimmune-pact-with-ai-biotech-could-reach-2-5b\/"},"modified":"2026-01-05T07:45:13","modified_gmt":"2026-01-05T12:45:13","slug":"sanofis-2nd-autoimmune-pact-with-ai-biotech-could-reach-2-5b","status":"publish","type":"post","link":"https:\/\/testing.news-you-need.com\/index.php\/2026\/01\/05\/sanofis-2nd-autoimmune-pact-with-ai-biotech-could-reach-2-5b\/","title":{"rendered":"Sanofi&#8217;s 2nd autoimmune pact with AI biotech could reach $2.5B"},"content":{"rendered":"<p><a href=\"https:\/\/www.fiercebiotech.com\/biotech\/sanofis-latest-autoimmune-bispecific-pact-ai-biotech-could-reach-25b\">Sanofi&#8217;s 2nd autoimmune pact with AI biotech could reach $2.5B<\/a><\/p>\n<p><a href=\"https:\/\/www.fiercebiotech.com\/biotech\/sanofis-latest-autoimmune-bispecific-pact-ai-biotech-could-reach-25b\">https:\/\/www.fiercebiotech.com\/biotech\/sanofis-latest-autoimmune-bispecific-pact-ai-biotech-could-reach-25b<\/a><\/p>\n<p>Publish Date: <a href=\"publish_date]\">2026-01-05 07:30:00<\/a><\/p>\n<p>Source Domain: <a href=\"www.fiercebiotech.com\">www.fiercebiotech.com<\/a><\/p>\n<ul>\n<li>\n<p><strong>New Collaboration Pact<\/strong>: Sanofi has renewed its partnership with U.S. biotech Earendil Labs for another major autoimmune and immunology research agreement.<\/p>\n<\/li>\n<li>\n<p><strong>Financial Commitment<\/strong>: Under this deal, Sanofi has pledged $160 million upfront and over the near-term to leverage Earendil&#8217;s discovery platform for multiple bispecific autoimmune and inflammatory disease projects.<\/p>\n<\/li>\n<li>\n<p><strong>Development and Commercialization<\/strong>: Sanofi will manage the development and commercialization efforts for all bispecific candidates derived from this collaboration.<\/p>\n<\/li>\n<li>\n<p><strong>Potential Total Deal Value<\/strong>: The deal contains potential milestone payments to Earendil that could escalate the overall value to up to $2.56 billion, in addition to royalties based on sales.<\/p>\n<\/li>\n<li>\n<p><strong>Previous Collaboration<\/strong>: This latest agreement follows an earlier pact from April 2025 where Sanofi invested $125 million for bispecific antibodies that target conditions such as ulcerative colitis and Crohn&#8217;s disease.<\/p>\n<\/li>\n<li>\n<p><strong>AI-Driven Platform<\/strong>: Earendil Lab\u2019s commitment to AI-driven research and development, including machine learning, helps in creating next-generation biologic therapeutics.<\/p>\n<\/li>\n<li>\n<p><strong>Ongoing Research<\/strong>: Earendil has completed a phase 1 study for HXN-1001, which aims at treating inflammatory bowel diseases.<\/p>\n<\/li>\n<li>\n<p><strong>Company Expansion<\/strong>: Sanofi has been expanding its autoimmune and immunology pipeline through various partnerships and investments, including a deal with Dren Bio worth up to $1.7 billion.<\/p>\n<\/li>\n<\/ul>\n<p><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Sanofi&#8217;s 2nd autoimmune pact with AI biotech could reach $2.5B https:\/\/www.fiercebiotech.com\/biotech\/sanofis-latest-autoimmune-bispecific-pact-ai-biotech-could-reach-25b Publish Date: 2026-01-05 07:30:00&#8230;<\/p>\n","protected":false},"author":1,"featured_media":174580,"comment_status":"closed","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"fifu_image_url":"https:\/\/qtxasset.com\/quartz\/qcloud5\/media\/image\/Sanofi_1.jpg?VersionId=_ldHGlZpkxvaLA71k7n0yuGtmyHNY93_","fifu_image_alt":"","footnotes":""},"categories":[14],"tags":[],"class_list":["post-174579","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-artificial-intelligence"],"_links":{"self":[{"href":"https:\/\/testing.news-you-need.com\/index.php\/wp-json\/wp\/v2\/posts\/174579"}],"collection":[{"href":"https:\/\/testing.news-you-need.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/testing.news-you-need.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/testing.news-you-need.com\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/testing.news-you-need.com\/index.php\/wp-json\/wp\/v2\/comments?post=174579"}],"version-history":[{"count":1,"href":"https:\/\/testing.news-you-need.com\/index.php\/wp-json\/wp\/v2\/posts\/174579\/revisions"}],"predecessor-version":[{"id":174581,"href":"https:\/\/testing.news-you-need.com\/index.php\/wp-json\/wp\/v2\/posts\/174579\/revisions\/174581"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/testing.news-you-need.com\/index.php\/wp-json\/wp\/v2\/media\/174580"}],"wp:attachment":[{"href":"https:\/\/testing.news-you-need.com\/index.php\/wp-json\/wp\/v2\/media?parent=174579"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/testing.news-you-need.com\/index.php\/wp-json\/wp\/v2\/categories?post=174579"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/testing.news-you-need.com\/index.php\/wp-json\/wp\/v2\/tags?post=174579"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}